Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
100 participants
INTERVENTIONAL
2023-05-01
2026-03-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The aim of our study is to evaluate the outcome of hardware removal surgery after a surgery of the ankle for a fracture. For that, we will perform do a controlled randomized trial with two arms: one arm includes the participants who will have a hardware removal and the other arm will not have a surgery.
Outcome parameters are the patients reported outcome and pain related disability. They will be assessed by the questionnaires FAAM score (Foot and Ankle Ability Measure) and PDI (Pain Disability Index) at the beginning and at the end of the study, at six months. The third outcome parameter will be the complication rate after an anklehardware removal surgery, which will be assessed through the Ernst-Ssink classification.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
AORIF Complex Ankle Fractures
NCT04033848
Comparison of the Results of Complex Ankle Fractures Treated With and Without Ankle Arthroscopy
NCT02449096
Operative Versus Non Operative Treatment for Unstable Ankle Fractures
NCT00336752
Fibular Fixation in Ankle Fractures:Plate Verses Nail.
NCT02507193
Routine Versus on Demand Removal of the Syndesmotic Screw
NCT02896998
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The planned intervention is the following: after an ORIF of the ankle, patients have a follow-up. At the 12- month control, we ask eligible patients if they want to participate to the study. If they agree, they are randomised to treatment recommendations in one of two groups: conservative or surgical. The patients may follow or not the recommendations; not following the recommendations does not exclude them from the study. Patients of both groups will fill out FAAM and PDI questionnaires at 12 and 18 months after the 1st operation. Patients in the surgical group will have a hardware removal surgery. It is a very common operation consisting of hardware removal that is done ambulatory by the orthopaedic surgeons specialized in foot and ankle surgery. Operated patients will have the usual postoperative follow-up (6 weeks, 3 months and 6 months postoperative) and all complications will be recorded and classified according to the Ernst-sink classification
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Hardware removal
hardware removal
Hardware removal
The surgery of hardware removal after an ORIF of an ankle fracture
hardware retaining
Patients that retain their hardware
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Hardware removal
The surgery of hardware removal after an ORIF of an ankle fracture
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Operative treatment of ankle/foot fractures at HFR or RHNe:
* Ankle fractures: bi-malleolar and tri-malleolar fractures or equivalent
* FAAM score \>5%, \<95%
* Patient expected to complete length of study
* Patient with sufficient cognitive and linguistic ability in order to participate in the study.
* Operable patients (ASA score ≤3)
Exclusion Criteria
* Ankle fractures that are not listed in the criteria above
* Patient treated for a fracture at the same foot/ ankle before
* Patient with fracture of two different regions of the foot/ankle
* Patient treated for the fracture outside of HFR and RHNe
* Patient non ambulating before time of injury
* Patients having diabete,
* immunocompromised under chemotherapy,
* Peripheral artery disease stade IV
* Pregnant patients
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hôpital Fribourgeois
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2023-00026
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.